Loading
Japanese surgeon who led JCOG0912, the trial that confirmed laparoscopic gastrectomy is not inferior to open surgery for early stomach cancer.
Hitoshi Katai is a gastric surgeon at the National Cancer Center Hospital in Tokyo. He was first author of the 2020 Lancet Gastroenterology and Hepatology report of JCOG0912, the Japan Clinical Oncology Group trial that showed laparoscopy-assisted distal gastrectomy was non-inferior to open distal gastrectomy for clinical stage I gastric cancer in relapse-free survival.
| Title | Journal | Year |
|---|---|---|
| JCOG0912: laparoscopy-assisted versus open distal gastrectomy for clinical stage IA or IB gastric cancer | The Lancet Gastroenterology and Hepatology | 2020 |
Shares Early gastric cancer, Gastric & gastro-oesophageal junction cancer and the tags gastric, surgery, trialist.
Shares Gastric & gastro-oesophageal junction cancer and the tags gastric, trialist.
Shares Gastric & gastro-oesophageal junction cancer and the tags gastric, trialist.
Shares JCOG0912: laparoscopy-assisted versus open distal gastrectomy for clinical stage IA or IB gastric cancer, Early gastric cancer, Gastric & gastro-oesophageal junction cancer.
Shares Gastric & gastro-oesophageal junction cancer and the tags gastric, trialist.
Shares Gastric & gastro-oesophageal junction cancer and the tags gastric, surgery.
Shares Gastric & gastro-oesophageal junction cancer and the tags gastric, trialist.
Shares Gastric & gastro-oesophageal junction cancer and the tags gastric, trialist.